Xtl Biopharmaceuticals Ltd Stock Price on July 29, 2024
| XTLB Stock | USD 2.07 0.03 1.43% |
Below is the normalized historical share price chart for XTL Biopharmaceuticals Ltd extending back to September 01, 2005. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of XTL Biopharmaceutica stands at 2.07, as last reported on the 28th of December, with the highest price reaching 2.29 and the lowest price hitting 2.03 during the day.
If you're considering investing in XTL Stock, it is important to understand the factors that can impact its price. At this point, XTL Biopharmaceutica is extremely dangerous. XTL Biopharmaceuticals shows Sharpe Ratio of 0.0104, which attests that the company had a 0.0104% return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for XTL Biopharmaceuticals, which you can use to evaluate the volatility of the company. Please check out XTL Biopharmaceutica's Mean Deviation of 4.88, risk adjusted performance of 0.015, and Downside Deviation of 7.1 to validate if the risk estimate we provide is consistent with the expected return of 0.0809%.
At present, XTL Biopharmaceutica's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Common Stock Total Equity is expected to grow to about 15.9 M, whereas Total Stockholder Equity is forecasted to decline to about 2.1 M. . At present, XTL Biopharmaceutica's Price Book Value Ratio is projected to increase slightly based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 30.04, whereas Price To Sales Ratio is forecasted to decline to 0.15. XTL Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 1st of September 2005 | 200 Day MA 2.3333 | 50 Day MA 1.8198 | Beta 0.996 |
XTL |
Sharpe Ratio = 0.0104
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | XTLB |
| Negative Returns |
Estimated Market Risk
| 7.77 actual daily | 69 69% of assets are less volatile |
Expected Return
| 0.08 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average XTL Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of XTL Biopharmaceutica by adding XTL Biopharmaceutica to a well-diversified portfolio.
Price Book 4.2303 | Book Value 0.005 | Enterprise Value 7.1 M | Enterprise Value Ebitda 11.2162 | Shares Float 487.7 M |
Related Headline
Fate Therapeutics Headline on 29th of July 2024
Insider Trading by Mozaffarian Neelufar Filed transaction by Fate Therapeutics Executive. Insider Public Trading |
XTL Biopharmaceutica Valuation on July 29, 2024
It is possible to determine the worth of XTL Biopharmaceutica on a given historical date. On July 29, 2024 XTL was worth 2.99 at the beginning of the trading date compared to the closed value of 2.97. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of XTL Biopharmaceutica stock. Still, in general, we apply an absolute valuation method to find XTL Biopharmaceutica's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of XTL Biopharmaceutica where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against XTL Biopharmaceutica's related companies.
| Open | High | Low | Close | Volume | |
| 2.97 | 2.98 | 2.62 | 2.98 | 6,800 | |
07/29/2024 | 2.99 | 3.04 | 2.89 | 2.97 | 18,900 |
| 2.98 | 2.98 | 2.90 | 2.98 | 6,464 |
| Backtest XTL Biopharmaceutica | | | XTL Biopharmaceutica History | | | XTL Biopharmaceutica Valuation | Previous | Next |
XTL Biopharmaceutica Trading Date Momentum on July 29, 2024
| On July 30 2024 XTL Biopharmaceuticals Ltd was traded for 2.98 at the closing time. The top price for the day was 2.98 and the lowest listed price was 2.90 . The trading volume for the day was 6.5 K. The trading history from July 30, 2024 was a factor to the next trading day price jump. The trading price change against the next closing price was 0.34% . The trading price change against the current closing price is 12.46% . |
XTL Biopharmaceuticals Fundamentals Correlations and Trends
By evaluating XTL Biopharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among XTL Biopharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. XTL financial account trend analysis is a perfect complement when working with valuation or volatility modules.About XTL Biopharmaceutica Stock history
XTL Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for XTL is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in XTL Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing XTL Biopharmaceutica stock prices may prove useful in developing a viable investing in XTL Biopharmaceutica
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 544.9 M | 572.2 M | |
| Net Loss | -1.6 M | -1.6 M |
XTL Biopharmaceutica Quarterly Net Working Capital |
|
XTL Biopharmaceutica Stock Technical Analysis
XTL Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
XTL Biopharmaceutica Period Price Range
Low | December 28, 2024
| High |
0.00 | 0.00 |
XTL Biopharmaceuticals Ltd cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
XTL Biopharmaceutica December 28, 2024 Market Strength
Market strength indicators help investors to evaluate how XTL Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading XTL Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying XTL Biopharmaceutica stock market strength indicators, traders can identify XTL Biopharmaceuticals Ltd entry and exit signals to maximize returns
XTL Biopharmaceutica Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for XTL Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of XTL Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of XTL to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.015 | |||
| Jensen Alpha | 0.0877 | |||
| Total Risk Alpha | (0.17) | |||
| Sortino Ratio | 0.0037 | |||
| Treynor Ratio | (0.03) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for XTL Stock analysis
When running XTL Biopharmaceutica's price analysis, check to measure XTL Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy XTL Biopharmaceutica is operating at the current time. Most of XTL Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of XTL Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move XTL Biopharmaceutica's price. Additionally, you may evaluate how the addition of XTL Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Global Correlations Find global opportunities by holding instruments from different markets |